Ligapar

Wirkstoff: ARCTIUM LAPPA ROOT, HUMAN LIGAMENT, SUS SCROFA CARTILAGE, ARNICA MONTANA WHOLE, BRYONIA ALBA ROOT, TRIBASIC CALCIUM PHOSPHATE, CAUSTICUM, RHODODENDRON AUREUM LEAF, TOXICODENDRON PUBESCENS LEAF, RUTA GRAVEOLENS FLOWERING TOP, SILICON DIOXIDE, ZINC

Flüssigkeit [Übersetzung der Form; Original: LIQUID (openFDA)] · ARCTIUM LAPPA ROOT 3 [hp_X]/mL, HUMAN LIGAMENT 8 [hp_X]/mL, SUS SCROFA CARTILAGE 8 [hp_X]/mL, ARNICA MONTANA WHOLE 12 [hp_X]/mL, BRYONIA ALBA ROOT 12 [hp_X]/mL, TRIBASIC CALCIUM PHOSPHATE 12 [hp_X]/mL, CAUSTICUM 12 [hp_X]/mL, RHODODENDRON AUREUM LEAF 12 [hp_X]/mL, TOXICODENDRON PUBESCENS LEAF 12 [hp_X]/mL, RUTA GRAVEOLENS FLOWERING TOP 12 [hp_X]/mL, SILICON DIOXIDE 12 [hp_X]/mL, ZINC 12 [hp_X]/mL

Vereinigte Staaten·Aktiv

Zulassungsinhaber: Energique, Inc.

Geprüft 2026-10-09 · openFDA NDC